Executive to join company on September 1.
After serving as CEO for Zimmer Biomet since 2017, Bryan Hanson has been appointed as the new CEO of 3M’s Health Care Business Group. Expected to take the reins when the independent health care company is spun off from 3M, Hanson will officially join the organization on September 1.
As a separate entity, 3M believes that Health Care Business Group will be better positioned to deliver industry-leading innovation that enables better, smarter, and safer healthcare for patients worldwide.
“We are pleased to have Bryan join us to advance the spin-off of our Health Care business and build a leading independent medical technology innovation company,” said Mike Roman, 3M chairman, CEO. “His industry expertise, ability to drive growth, and track record of building a strong culture and teams will make an immediate impact.”
Reference: Bryan Hanson Named CEO of 3M’s Health Care Business Group. 3M. August 22, 2023. Accessed August 23, 2023. https://news.3m.com/Bryan-Hanson-Named-CEO-of-3Ms-Health-Care-Business-Group
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.
The Transformative Role of Medical Information in Customer Engagement
October 3rd 2024Stacey Fung, Head of Global Medical Information at Gilead Lifesciences, delves into the evolving role of Medical Information (MI) in the pharmaceutical industry. Covering key topics like patient engagement through omnichannel strategies, combating misinformation, and leveraging AI to enhance medical inquiries, the conversation with Stacey highlights MI's critical role in ensuring patient safety and supporting drug development. She also shares her professional journey and tidbits for early career professionals on professional development.
Recent Developments in Pharmaceutical Validation
November 1st 2024Explore the latest pharmaceutical validation developments with industry experts from Barry-Wehmiller Design Group, Kneat Solutions, and No Deviation. You’ll gain valuable data-driven insights and discover emerging trends from the State of Validation 2024 industry report that are shaping the validation landscape.